{"disease":{"id":"neurofibromatosis-2","name":"neurofibromatosis 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03893643","title":"Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04463316","title":"GROWing Up With Rare GENEtic Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"dr. Laura C. G. de Graaff-Herder","has_results":false},{"nct_id":"NCT03406208","title":"Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing","phase":"NA","overall_status":"COMPLETED","enrollment_count":228,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01552434","title":"Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":155,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04374305","title":"Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Scott R. Plotkin, MD, PhD","has_results":false},{"nct_id":"NCT04890132","title":"Vestibular Precision: Physiology & Pathophysiology","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT03210285","title":"WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT01125046","title":"Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT03672838","title":"A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT03617276","title":"Reliability of Functional Outcome Measures in Neurofibromatosis 2","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05130866","title":"Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Recursion Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT01767792","title":"Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT02831257","title":"AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT05685836","title":"89Zr-Bevacizumab PET/CT Imaging in NF2 Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT04283669","title":"Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT00911248","title":"PTC299 for Treatment of Neurofibromatosis Type 2","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT03095248","title":"Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT02246231","title":"Effect of Implant Position on Magnetic Resonance Image Distortion","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT01345136","title":"Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02589912","title":"Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}